跳至主要内容
临床试验/NCT02599740
NCT02599740已完成不适用

The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels

Unilever R&D1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
1
主要终点
Change of 2-h Post Prandial Blood Glucose (PPG) based on response to different treatments

研究概览

简要总结

This study is designed to test bioequivalence of a assumed key active compound vs. natural fruit extract as judged from the Incremental area under the curve (+iAUC0-2h) for blood glucose: i.e. the 90% confidence interval of the ratio +iAUC0-2h for blood glucose for assumed key active compound vs. natural extract falls between 0.8 - 1.25.

详细描述

The basic study design for this Williams design consists of six distinct treatment sequences; within each of the treatment sequences the treatments are duplicated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index (BMI) ≥ 18.5 and ≤ 25.0 kg/m
  • Apparently healthy males and females: no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery [with exception of cholecystectomy and appendectomy] and inflammatory diseases).
  • Fasting blood glucose value of subjects is ≥ 3.4 and <6.1 mmol/litre (i.e. 62- 110 mg/dl) at screening.

排除标准

  • Use of antibiotics within 3 months before day 1; use of any other medication within 14 days before day 1 except for both paracetamol and hormonal contraception.

结局指标

主要结局

Change of 2-h Post Prandial Blood Glucose (PPG) based on response to different treatments

时间窗: 0-2 hours

+iAUC

次要结局

  • Change of 3-h PPG based on response to different treatments(0-3 hours)
  • Change of 2-h and 3-h post-prandial insulin based on response to different treatments(0-2 hours and 0-3 hours)
  • Half-life of elimination phase for assumed key active(0-12 hours)
  • Total amount of assumed key active excreted in urine(0-36 hours)
  • Time of max plasma concentration for assumed key active(0-12 hours)
  • Max plasma concentration for assumed key active(0-12 hours)
  • AUC for plasma concentration versus time curve for assumed key active(0-12 hours)

研究者

发起方
Unilever R&D
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验